{"id":46249,"date":"2025-01-28T11:12:15","date_gmt":"2025-01-28T16:12:15","guid":{"rendered":"https:\/\/biospringer.com\/?p=46249"},"modified":"2025-11-26T12:29:19","modified_gmt":"2025-11-26T17:29:19","slug":"how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry","status":"publish","type":"post","link":"https:\/\/biospringer.com\/en\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\/","title":{"rendered":"How is the rise of GLP-1 medications reshaping the food industry?"},"content":{"rendered":"

[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” z_index=”” css=”.vc_custom_1738078190432{padding-top: 30px !important;padding-bottom: 30px !important;}”][vc_column][vc_column_text css=””]<\/p>\n

In the United States, the rapid adoption of GLP-1 (glucagon-like peptide) drugs, such as Ozempic and Wegovy, is significantly influencing the food and beverage industry. These medications are driving a profound shift in consumer behavior, disrupting long-established norms. From changing dietary preferences to declining sales of indulgent products, GLP medications are rewriting the rules for how consumers interact with food.<\/p>\n

In this article, we\u2019ll explore GLP-1 drugs and their effects on consumer purchasing behavior. We\u2019ll examine the implications for the food industry, uncover how food manufacturers can adapt to these evolving consumption habits, and introduce Biospringer by Lesaffre yeast-based solutions<\/strong> designed to help address reformulation challenges effectively.<\/p>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” z_index=””][vc_column][vc_column_text css=””]<\/p>\n

What are GLP-1 medications?<\/strong><\/span><\/h2>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” z_index=”” css=”.vc_custom_1738078380984{padding-top: 20px !important;}”][vc_column width=”2\/3″][vc_column_text css=””]<\/p>\n

Initially designed for managing Type 2 diabetes and weight loss, these medications are now influencing a far broader spectrum of daily life. GLP drugs mimic the natural hormones in the body that regulate blood sugar and appetite. By slowing gastric emptying and increasing satiety, they help users manage their weight more effectively<\/strong>. (Circana \u2018GLP-1 Report\u2019, Dec 2024)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/em><\/p>\n

\u00a0<\/em>In fact, the new class of obesity medicines can reduce calorie intake by 20% to 30% daily,<\/strong> according to findings from a Morgan Stanley research survey of 300 patients taking the drugs.<\/p>\n

Their popularity stems from clinical effectiveness and endorsements by high-profile individuals, leading to a surge in prescriptions. According to recent studies, the global GLP-1 market is even forecast to grow at a 29.6 percent compound annual growth rate through 2030<\/strong>. (Research and Markets, \u201cGlobal Glucagon-Like Peptide 1 (GLP-1) Agonist market 2024 Edition)<\/em><\/p>\n

[\/vc_column_text][\/vc_column][vc_column width=”1\/3″ css=”.vc_custom_1738078395489{padding-top: 0px !important;}”][vc_single_image image=”46286″ img_size=”full” css=”” qode_css_animation=””][\/vc_column][\/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” z_index=”” css=”.vc_custom_1738076476456{padding-top: 50px !important;}”][vc_column][vc_column_text css=””]<\/p>\n

How GLP-1 medications impact consumers purchase behavior? <\/strong><\/span><\/h2>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” z_index=”” css=”.vc_custom_1738080063171{padding-top: 15px !important;}”][vc_column width=”1\/3″ css=”.vc_custom_1738078466003{padding-top: 10px !important;}”][vc_single_image image=”46328″ img_size=”full” css=”” qode_css_animation=””][\/vc_column][vc_column width=”2\/3″ css=”.vc_custom_1738080073447{padding-top: 10px !important;}”][vc_column_text css=””]The rise of GLP-1 drugs is already influencing how consumers approach food, reshaping spending habits and dietary preferences.<\/p>\n

Recent research reveals that while around 15% of households have at least one member using GLP-1 medications, only 7-8% of households consistently utilize these prescriptions. Among those consistent GLP-1 users, the impact on grocery spending is significant. Households with GLP-1 users saw an overall 6% decline in grocery expenditures,<\/strong> with higher-income households experiencing a more pronounced 9% drop. (Numerator study \u2018The No-Hunger Games: How GLP-1 Medication Adoption is Changing Consumer Food Purchases\u2019, Jan 2025)<\/em>[\/vc_column_text][\/vc_column][\/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” z_index=”” css=”.vc_custom_1738080083720{padding-top: 20px !important;}”][vc_column width=”2\/3″ css=”.vc_custom_1738080091171{padding-top: 20px !important;}”][vc_column_text css=””]The categories hit hardest by this shift in consumer behavior are chips\/salty snacks (down 11.1%) <\/strong>and sweet baked goods (down 6.7%).<\/strong> GLP-1 medications tend to curb cravings for these indulgent, high-calorie items, leading to the highest declines in these segments. (Numerator study)<\/em><\/p>\n

In the foodservice realm, GLP-1 weight loss users initially skew their spending toward quick-service restaurants (QSRs). However, over the course of their first year on the medication, they gradually shift their dollars toward grocery foodservice, casual dining, and midscale restaurants. (Circana study)<\/em> Fast food consumption decreased 12% <\/strong>among lower income households, as GLP-1 users are tending to skip breakfast and seek to cook healthier foods for dinner at home.<\/strong> (Numerator study)<\/em>[\/vc_column_text][\/vc_column][vc_column width=”1\/3″ css=”.vc_custom_1738080097355{padding-top: 20px !important;}”][vc_single_image image=”46321″ img_size=”full” css=”” qode_css_animation=””][\/vc_column][\/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” z_index=”” css=”.vc_custom_1738080108426{padding-top: 20px !important;}”][vc_column css=”.vc_custom_1738080112294{padding-top: 20px !important;}”][vc_column_text css=””]<\/p>\n

These insights underscore the profound impact GLP-1 medications are having on consumer purchasing habits across both retail and foodservice channels<\/strong>. As this trend continues to evolve, food and beverage brands will need to closely monitor shifting preferences and adapt their product portfolios accordingly.<\/p>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” z_index=”” css=”.vc_custom_1738079181122{padding-top: 50px !important;padding-bottom: 10px !important;}”][vc_column][vc_column_text css=”.vc_custom_1738080290099{padding-bottom: 10px !important;}”]<\/p>\n

Manufacturers face reformulation challenges as well as innovation opportunities.<\/strong><\/span><\/h2>\n

[\/vc_column_text][vc_column_text css=””]For food manufacturers, the growing adoption of GLP-1 medications presents both challenges and opportunities.<\/strong> As consumer demand shifts toward healthier, reformulated products, brands must adapt their offerings to align with these preferences.<\/p>\n

The growing prevalence of GLP-1 medication use is driving increased demand for foods and beverages that are lower in sugar, carbohydrates, and calories, yet still satisfying and flavorful.<\/strong> Brands can develop and promote offerings that align with the dietary needs of GLP-1 users, such as high-protein, low-calorie, and portion-controlled options<\/strong> that support feelings of satiety and healthy blood sugar regulation.<\/p>\n

Food manufacturers are facing new technical challenges in reformulating products with less salt and fat to support GLP-1 users on their health and weight loss journey. Innovative ingredient technologies, such as yeast-based solutions<\/a>, can play a pivotal role in helping brands develop GLP-1 friendly products that deliver on taste and nutrition.[\/vc_column_text][\/vc_column][\/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”center” background_image_as_pattern=”without_pattern” z_index=”” css=”.vc_custom_1738079300503{padding-top: 25px !important;padding-bottom: 25px !important;}”][vc_column]Contact our experts to learn more<\/a>[\/vc_column][\/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” z_index=”” css=”.vc_custom_1738079072854{padding-top: 5px !important;}”][vc_column][vc_column_text css=”.vc_custom_1738078707562{padding-bottom: 10px !important;}”]<\/p>\n

Biospringer by Lesaffre offer innovative yeast-based solutions to develop healthier food.<\/strong><\/span><\/h2>\n

[\/vc_column_text][vc_column_text css=””]At Biospringer by Lesaffre<\/strong>, we specialize in fermentation-based ingredients that help food manufacturers overcome the challenges of reformulating products for GLP-1 users and other health-conscious consumers. Our yeast-based solutions are designed to support healthier eating habits without compromising on taste.<\/p>\n

For instance, the Springer\u00ae Umami range allows manufacturers to reduce salt content<\/span><\/strong> while maintaining flavor intensity, providing a satisfying taste experience even in low-sodium products. Similarly, our Springer\u00a0\u00ae<\/sup>\u00a0Cocoon\u00a0<\/a>range enables fat reduction<\/span><\/strong> of up to 30%<\/strong> thanks to creaminess improvement by delivering rich, full-bodied flavors and textures.<\/p>\n

When it comes to sugar reduction,<\/span><\/strong> our ranges offer various benefits that intensify sweetness or allow sugar reduction by bringing specific flavor notes, making it possible to cut sugar without sacrificing the sensory appeal of a product. For example, Springer\u00a0\u00ae<\/sup>\u00a0Umami<\/strong><\/a>\u00a0<\/strong>will bring an umami and roundness sensation, while\u00a0Springer\u00a0\u00ae<\/sup>\u00a0Reveal\u00a0<\/strong><\/a>will intensify the sweetness, allowing a sugar reduction of 20% in tomato sauce. In chocolate cookies,\u00a0Springer\u00a0\u00ae<\/sup>\u00a0Signature range<\/strong><\/a>\u00a0<\/strong>brings specific cacao and roasted flavors notes, leading to a sugar reduction of 30%.<\/p>\n

For protein enrichment,<\/span><\/strong> our Springer Proteissimo<\/strong>\u00ae range<\/strong> delivers high-quality protein that can be seamlessly incorporated into a variety of food and beverage applications without introducing off-notes, ensuring nutritional balance and consumer satisfaction.<\/p>\n

By partnering with Biospringer by Lesaffre, manufacturers can confidently reformulate their products to align with evolving consumer preferences while maintaining the quality and sensory appeal that today\u2019s consumers expect.<\/span><\/strong><\/p>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” z_index=”” css=”.vc_custom_1738076178323{padding-top: 50px !important;}”][vc_column][vc_column_text css=”.vc_custom_1738331323572{padding-bottom: 10px !important;}”]<\/p>\n

How can companies take advantage of the new consumption habits of GLP-1 users?<\/strong><\/span><\/h2>\n

[\/vc_column_text][vc_column_text css=””]\"Uma<\/p>\n

The rise of GLP-1 medications presents a unique opportunity for food and beverage companies to innovate and grow their market share.<\/strong> By aligning product development with the evolving preferences of this growing consumer segment, businesses can not only mitigate risks associated with reduced consumption but also unlock new revenue streams.<\/p>\n

To seize this opportunity, it\u2019s essential for companies to understand the behavioral shifts among GLP-1 users. With reduced cravings for high-calorie, indulgent products and an increasing preference for healthier, nutrient-rich options, brands must recalibrate their portfolios to meet these demands.<\/strong> Introducing products that are low in calories, sugar, and fat, yet satisfying and flavorful, will be key to staying relevant.<\/p>\n

Proactive planning is crucial as the adoption of GLP-1 medications continues to rise. As these drugs become more affordable and accessible, their influence on consumer behavior will only grow. Companies that act now to incorporate health-focused innovations into their product lines will be better positioned to capture a greater share of this expanding market.<\/p>\n

[\/vc_column_text][vc_column_text css=”.vc_custom_1738080252772{padding-top: 25px !important;}”]<\/p>\n

At Biospringer by Lesaffre, our team of experts is ready to help food manufacturers navigate these changes. By leveraging our innovative yeast-based solutions, businesses can create products that cater to GLP-1 users\u2019 preferences without sacrificing taste or quality.<\/strong><\/p>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”center” background_image_as_pattern=”without_pattern” z_index=””][vc_column]Contact us today to learn how Biospringer can support your GLP-1-friendly product development journey.<\/a>[\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Thanks to yeast-based solutions, food manufacturers can adapt to the changes in consumption habits brought about by GLP-1 medications.<\/p>\n","protected":false},"author":17,"featured_media":51061,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-46249","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-salt-reduction"],"acf":[],"yoast_head":"\nHow is the rise of GLP-1 medications reshaping the food industry?<\/title>\n<meta name=\"description\" content=\"Thanks to yeast-based solutions, food manufacturers can adapt to the changes in consumption habits brought about by GLP-1 medications.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/biospringer.com\/en\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How is the rise of GLP-1 medications reshaping the food industry?\" \/>\n<meta property=\"og:description\" content=\"Thanks to yeast-based solutions, food manufacturers can adapt to the changes in consumption habits brought about by GLP-1 medications.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/biospringer.com\/en\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\/\" \/>\n<meta property=\"og:site_name\" content=\"Biospringer\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-28T16:12:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-26T17:29:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/biospringer.com\/wp-content\/uploads\/2025\/01\/Plan-de-travail-125.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1920\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Sophie LAUGIER\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sophie LAUGIER\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/biospringer.com\\\/en\\\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/biospringer.com\\\/en\\\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\\\/\"},\"author\":{\"name\":\"Sophie LAUGIER\",\"@id\":\"https:\\\/\\\/biospringer.com\\\/en\\\/#\\\/schema\\\/person\\\/8b916848ef6e1b2826a4a85d95079426\"},\"headline\":\"How is the rise of GLP-1 medications reshaping the food industry?\",\"datePublished\":\"2025-01-28T16:12:15+00:00\",\"dateModified\":\"2025-11-26T17:29:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/biospringer.com\\\/en\\\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\\\/\"},\"wordCount\":1913,\"publisher\":{\"@id\":\"https:\\\/\\\/biospringer.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/biospringer.com\\\/en\\\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/biospringer.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Plan-de-travail-125.png\",\"articleSection\":[\"salt reduction\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/biospringer.com\\\/en\\\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\\\/\",\"url\":\"https:\\\/\\\/biospringer.com\\\/en\\\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\\\/\",\"name\":\"How is the rise of GLP-1 medications reshaping the food industry?\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/biospringer.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/biospringer.com\\\/en\\\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/biospringer.com\\\/en\\\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/biospringer.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Plan-de-travail-125.png\",\"datePublished\":\"2025-01-28T16:12:15+00:00\",\"dateModified\":\"2025-11-26T17:29:19+00:00\",\"description\":\"Thanks to yeast-based solutions, food manufacturers can adapt to the changes in consumption habits brought about by GLP-1 medications.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/biospringer.com\\\/en\\\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/biospringer.com\\\/en\\\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/biospringer.com\\\/en\\\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\\\/#primaryimage\",\"url\":\"https:\\\/\\\/biospringer.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Plan-de-travail-125.png\",\"contentUrl\":\"https:\\\/\\\/biospringer.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Plan-de-travail-125.png\",\"width\":2560,\"height\":1920,\"caption\":\"How GLP 1 medications are reshaping the food industry\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/biospringer.com\\\/en\\\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/biospringer.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How is the rise of GLP-1 medications reshaping the food industry?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/biospringer.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/biospringer.com\\\/en\\\/\",\"name\":\"Biospringer\",\"description\":\"Global yeast extract producer\",\"publisher\":{\"@id\":\"https:\\\/\\\/biospringer.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/biospringer.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/biospringer.com\\\/en\\\/#organization\",\"name\":\"Biospringer by Lesaffre\",\"url\":\"https:\\\/\\\/biospringer.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/biospringer.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/biospringer.com\\\/wp-content\\\/uploads\\\/2019\\\/06\\\/logo-Biospringer.png\",\"contentUrl\":\"https:\\\/\\\/biospringer.com\\\/wp-content\\\/uploads\\\/2019\\\/06\\\/logo-Biospringer.png\",\"width\":400,\"height\":100,\"caption\":\"Biospringer by Lesaffre\"},\"image\":{\"@id\":\"https:\\\/\\\/biospringer.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/fr.linkedin.com\\\/company\\\/biospringer\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCIwlo39VHSwHryOBeg3w-rw\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/biospringer.com\\\/en\\\/#\\\/schema\\\/person\\\/8b916848ef6e1b2826a4a85d95079426\",\"name\":\"Sophie LAUGIER\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How is the rise of GLP-1 medications reshaping the food industry?","description":"Thanks to yeast-based solutions, food manufacturers can adapt to the changes in consumption habits brought about by GLP-1 medications.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/biospringer.com\/en\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\/","og_locale":"en_US","og_type":"article","og_title":"How is the rise of GLP-1 medications reshaping the food industry?","og_description":"Thanks to yeast-based solutions, food manufacturers can adapt to the changes in consumption habits brought about by GLP-1 medications.","og_url":"https:\/\/biospringer.com\/en\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\/","og_site_name":"Biospringer","article_published_time":"2025-01-28T16:12:15+00:00","article_modified_time":"2025-11-26T17:29:19+00:00","og_image":[{"width":2560,"height":1920,"url":"https:\/\/biospringer.com\/wp-content\/uploads\/2025\/01\/Plan-de-travail-125.png","type":"image\/png"}],"author":"Sophie LAUGIER","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Sophie LAUGIER","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/biospringer.com\/en\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\/#article","isPartOf":{"@id":"https:\/\/biospringer.com\/en\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\/"},"author":{"name":"Sophie LAUGIER","@id":"https:\/\/biospringer.com\/en\/#\/schema\/person\/8b916848ef6e1b2826a4a85d95079426"},"headline":"How is the rise of GLP-1 medications reshaping the food industry?","datePublished":"2025-01-28T16:12:15+00:00","dateModified":"2025-11-26T17:29:19+00:00","mainEntityOfPage":{"@id":"https:\/\/biospringer.com\/en\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\/"},"wordCount":1913,"publisher":{"@id":"https:\/\/biospringer.com\/en\/#organization"},"image":{"@id":"https:\/\/biospringer.com\/en\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\/#primaryimage"},"thumbnailUrl":"https:\/\/biospringer.com\/wp-content\/uploads\/2025\/01\/Plan-de-travail-125.png","articleSection":["salt reduction"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/biospringer.com\/en\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\/","url":"https:\/\/biospringer.com\/en\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\/","name":"How is the rise of GLP-1 medications reshaping the food industry?","isPartOf":{"@id":"https:\/\/biospringer.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/biospringer.com\/en\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\/#primaryimage"},"image":{"@id":"https:\/\/biospringer.com\/en\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\/#primaryimage"},"thumbnailUrl":"https:\/\/biospringer.com\/wp-content\/uploads\/2025\/01\/Plan-de-travail-125.png","datePublished":"2025-01-28T16:12:15+00:00","dateModified":"2025-11-26T17:29:19+00:00","description":"Thanks to yeast-based solutions, food manufacturers can adapt to the changes in consumption habits brought about by GLP-1 medications.","breadcrumb":{"@id":"https:\/\/biospringer.com\/en\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/biospringer.com\/en\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/biospringer.com\/en\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\/#primaryimage","url":"https:\/\/biospringer.com\/wp-content\/uploads\/2025\/01\/Plan-de-travail-125.png","contentUrl":"https:\/\/biospringer.com\/wp-content\/uploads\/2025\/01\/Plan-de-travail-125.png","width":2560,"height":1920,"caption":"How GLP 1 medications are reshaping the food industry"},{"@type":"BreadcrumbList","@id":"https:\/\/biospringer.com\/en\/how-the-rise-of-glp-1-medications-is-reshaping-the-food-industry\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/biospringer.com\/en\/"},{"@type":"ListItem","position":2,"name":"How is the rise of GLP-1 medications reshaping the food industry?"}]},{"@type":"WebSite","@id":"https:\/\/biospringer.com\/en\/#website","url":"https:\/\/biospringer.com\/en\/","name":"Biospringer","description":"Global yeast extract producer","publisher":{"@id":"https:\/\/biospringer.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/biospringer.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/biospringer.com\/en\/#organization","name":"Biospringer by Lesaffre","url":"https:\/\/biospringer.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/biospringer.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/biospringer.com\/wp-content\/uploads\/2019\/06\/logo-Biospringer.png","contentUrl":"https:\/\/biospringer.com\/wp-content\/uploads\/2019\/06\/logo-Biospringer.png","width":400,"height":100,"caption":"Biospringer by Lesaffre"},"image":{"@id":"https:\/\/biospringer.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/fr.linkedin.com\/company\/biospringer","https:\/\/www.youtube.com\/channel\/UCIwlo39VHSwHryOBeg3w-rw"]},{"@type":"Person","@id":"https:\/\/biospringer.com\/en\/#\/schema\/person\/8b916848ef6e1b2826a4a85d95079426","name":"Sophie LAUGIER"}]}},"_links":{"self":[{"href":"https:\/\/biospringer.com\/en\/wp-json\/wp\/v2\/posts\/46249","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biospringer.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/biospringer.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/biospringer.com\/en\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/biospringer.com\/en\/wp-json\/wp\/v2\/comments?post=46249"}],"version-history":[{"count":0,"href":"https:\/\/biospringer.com\/en\/wp-json\/wp\/v2\/posts\/46249\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/biospringer.com\/en\/wp-json\/wp\/v2\/media\/51061"}],"wp:attachment":[{"href":"https:\/\/biospringer.com\/en\/wp-json\/wp\/v2\/media?parent=46249"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/biospringer.com\/en\/wp-json\/wp\/v2\/categories?post=46249"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/biospringer.com\/en\/wp-json\/wp\/v2\/tags?post=46249"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}